Title:
Composite shaped bodies and methods for their production and use
Document Type and Number:
Kind Code:
A1

Abstract:
Shaped, composite bodies are provided. One portion of the shaped bodies comprises an RPR-derived porous inorganic material, preferably a calcium phosphate. Another portion of the composite bodies is a different solid material, preferably metal, glass, ceramic or polymeric. The shaped bodies are especially suitable for orthopaedic and other surgical use.
Inventors:
Koblish, Antony (Malvern, PA, US)
Sapieszko, Ronald (Woodbury, MN, US)
Dychala, David (West Chester, PA, US)
Erbe, Erik (Berwyn, PA, US)
Application Number:
10/165629
Publication Date:
07/24/2003
Filing Date:
06/07/2002
View Patent Images:
Images are available in PDF form when logged in. To view PDFs, Login  or  Create Account (Free!)
Primary Class:
Other Classes:
623/23.500, 424/423
International Classes:
(IPC1-7): A61F002/28
Attorney, Agent or Firm:
WOODCOCK WASHBURN LLP (ONE LIBERTY PLACE, 46TH FLOOR, PHILADELPHIA, PA, 19103, US)
Claims:

What is claimed is:



1. A shaped body comprising: a first segment comprising a polymerizable matrix and an inorganic filler; and in contact with at least a portion of the first segment, a second segment comprising an inorganic material having substantially uniform macro-, meso- and microporosity together with a pore volume of at least about 30%.

2. The shaped body of claim lwherein the inorganic material comprises calcium phosphate.

3. The shaped body of claim 1 wherein the pore volume of the inorganic material is at least about 50%.

4. The shaped body of claim 1 wherein the pore volume of the inorgaric material is at least about 70%.

5. The shaped body of claim 1 wherein the pore volume of the inorganic material is at least about 90%.

6. A composite body having at least two portions: a first portion comprising the oxidation-reaction product of a blend comprising at least one metal cation; at least one oxidizing agent; and at least one precursor anion oxidizable by said oxidizing agent to form an oxoanion; the second portion being imbibed into the first portion.

7. The composite body of claim 6 wherein the second portion is polymerized.

8. The composite body of claim 6 wherein the second portion is selected from the group consisting of polycaprolactones, polyglycolic acid, poly-L-lactic acid, polysulfones, polyolefins, polyvinyl alcohol, polyalkenoics, polyacrylic acids, and polyesters.

9. A composite body for drug delivery comprising: a first portion comprising the oxidation-reaction product of a blend comprising at least one metal cation; at least one oxidizing agent; and at least one precursor anion oxidizable by said oxidizing agent to form an oxoanion; a second, resorbable portion imbibed into the first portion; and a medicament.

10. The composite shaped body of claim 9 wherein the medicament is absorbed into the solid composite body.

11. The composite shaped body of claim 9 wherein the medicament is a growth hormone, antibiotic material, proteins, cell signaling material, steroids, analgesics, or fertility drugs.

12. A shaped body comprising: a first portion comprised of an inorganic material having substantially uniform macro-, meso- and microporosity together with a pore volume of at least about 30%; and a second portion that contacts at least a portion of the first portion, wherein the second portion is comprised of a powder.

13. The shaped body of claim 12 wherein the powder is L-lactic acid.

14. A shaped body comprising: a first portion comprised of an inorganic material having substantially uniform macro-, meso- and microporosity together with a pore volume of at least about 30%; and a second portion that contacts at least a portion of the first portion, wherein the first portion is a hollow sleeve.

15. The shaped body of claim 14 wherein the second portion is a graft material.

16. The shaped body of claim 14 wherein the second portion is a hardenable fluid material.

17. The shaped body of claim 16 wherein the fluid material is a liquid, paste, putty or gel.

18. The shaped body of claim 16 wherein the fluid material is polymerizable.

19. The shaped body of claim 16 wherein the fluid material is acrylic.

20. The shaped body of claim 14 wherein the outer surface of the hollow sleeve includes a plurality of orifices.

Description:

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application is a continuation-in-part of U.S. application Ser. No. 09/373,796, the contents of which are incorporated herein by reference in their entirety.

FIELD OF THE INVENTION

[0002] This invention relates to the preparation of composite shaped bodies, especially those having at least a portion comprising a calcium phosphate-containing material. This invention also relates to methods for preparing the bodies and to methods for use thereof. In accordance with certain embodiments of this invention, shaped bodies are provided which are at once, possessed of two or more portions having different properties. In accordance with other preferred embodiments, at least one portion of the composite is highly porous and uniform in composition. The shaped bodies can be produce in a wide range of geometric configurations through novel, low temperature techniques. The shaped bodies of the invention can have portions which are highly and uniformly porous while being self-supporting. They can be strengthened further using a variety of techniques, thereby forming porous composite structures. Such composite structures are useful as cell growth scaffolds, bone grafting materials, drug delivery vehicles, biological separation/purification media, catalysis and other supports and in a wide range of other uses. One of the most preferred uses for the composite structures of this invention is in the field of orthopaedic, restorative and reconstructive surgery. Thus, the present invention provides shaped bodies having highly suitable combinations of properties which make those bodies extraordinarily useful for bone replacement, spinal repair; reconstructive, cosmetic and other surgeries.

BACKGROUND OF THE INVENTION

[0003] There has been a continuing need for improved methods for the preparation of mineral compositions, especially calcium phosphate-containing minerals. This long-felt need is reflected in part by the great amount of research found in the pertinent literature. While such interest and need stems from a number of industrial interests, the desire to provide materials which closely mimic mammalian bone for use in repair and replacement of such bone has been a major motivating force. Such minerals are principally calcium phosphate apatites as found in teeth and bones. For example, type-B carbonated hydroxyapatite [Ca5(PO4)3-x(CO3)x(OH)] is the principal mineral phase found in the body, with variations in protein and organic content determining the ultimate composition, crystal size, morphology, and structure of the body portions formed therefrom.

[0004] Calcium phosphate ceramics have been fabricated and implanted in mammals in various forms including, but not limited to, shaped bodies and cements. Different stoichiometric compositions such as hydroxyapatite (HAp), tricalcium phosphate (TCP), tetracalcium phosphate (TTCP), and other calcium phosphate salts and minerals, have all been employed to this end in an attempt to match the adaptability, biocompatibility, structure, and strength of natural bone. The role of pore size and porosity in promoting revascularization, healing, and remodeling of bone is now recognized as a critical property for bone replacement materials. Despite tremendous efforts directed to the preparation of porous calcium phosphate materials for such uses, significant shortcomings still remain. This invention overcomes those shortcomings and describes porous calcium phosphate and a wide variety of other inorganic materials which, in the case of calcium phosphates, closely resemble bone, and methods for the fabrication of such materials as shaped bodies for biological, chemical, industrial, and many other applications.

[0005] Early ceramic biomaterials exhibited problems derived from chemical and processing shortcomings that limited stoichiometric control, crystal morphology, surface properties, and, ultimately, reactivity in the body. Intensive milling and comminution of natural minerals of varying composition was required, followed by powder blending and ceramic processing at high temperatures to synthesize new phases for use in vivo.

[0006] A number of patents have issued which relate to ceramic biomaterials and are incorporated herein by reference. Among these are U.S. Pat. No. 4,880,610, B. R. Constantz, “In situ calcium phosphate minerals—method and composition;” U.S. Pat. No. 5,047,031, B. R. Constantz, “In situ calcium phosphate minerals method;” U.S. Pat. No. 5,129,905, B. R. Constantz, “Method for in situ prepared calcium phosphate minerals;” U.S. Pat. No. 4,149,893, H. Aoki, et al, “Orthopaedic and dental implant ceramic composition and process for preparing same;” U.S. Pat. No. 4,612,053, W. E. Brown, et al, “Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements;” U.S. Pat. No. 4,673,355, E. T. Farris, et al, “Solid calcium phosphate materials;” U.S. Pat. No. 4,849,193, J. W. Palmer, et al., “Process of preparing hydroxyapatite;” U.S. Pat. No. 4,897,250, M. Sumita, “Process for producing calcium phosphate;” U.S. Pat. No. 5,322,675, Y. Hakamatsuka, “Method of preparing calcium phosphate;” U.S. Pat. No. 5,338,356, M. Hirano, et al “Calcium phosphate granular cement and method for producing same;” U.S. Pat. No. 5,427,754, F. Nagata, et al., “Method for production of platelike hydroxyapatite;” U.S. Pat. No. 5,496,399, I. C. Ison, et al., “Storage stable calcium phosphate cements;” U.S. Pat. No. 5,522,893, L. C. Chow. et al., “Calcium phosphate hydroxyapatite precursor and methods for making and using same;” U.S. Pat. No. 5,545,254, L. C. Chow, et al., “Calcium phosphate hydroxyapatite precursor and methods for making and using same;” U.S. Pat. No. 3,679,360, B. Rubin, et al., “Process for the preparation of brushite crystals;” U.S. Pat. No. 5,525,148, L. C. Chow, et al., “Self-setting calcium phosphate cements and methods for preparing and using them;” U.S. Pat. No. 5,034,352, J. Vit, et al., “Calcium phosphate materials;” and U.S. Pat. No. 5,409,982, A. Imura, et al “Tetracalcium phosphate-based materials and process for their preparation.”

[0007] Several patents describe the preparation of porous inorganic or ceramic structures using polymeric foams impregnated with a slurry of preformed ceramic particles. These are incorporated herein by reference: U.S. Pat. No. 3,833,386, L. L. Wood, et al, “Method of preparing porous ceramic structures by firing a polyurethane foam that is impregnated with inorganic material;” U.S. Pat. No. 3,877,973, F. E. G. Ravault, “Treatment of permeable materials;” U.S. Pat. No. 3,907,579, F. E. G. Ravault, “Manufacture of porous ceramic materials;” and U.S. Pat. No. 4,004,933, F. E. G. Ravault, “Production of porous ceramic materials.” However, none of aforementioned art specifically describes the preparation of porous metal or calcium phosphates and none employs the methods of this invention.

[0008] The prior art also describes the use of solution impregnated-polymeric foams to produce porous ceramic articles and these are incorporated herein by reference: U.S. Pat. No. 3,090,094, K. Schwartzwalder, et al, “Method of making porous ceramic articles;” U.S. Pat. No. 4,328,034 C. N. Ferguson, “Foam Composition and Process;” U.S. Pat. No. 4,859,383, M. E. Dillon, “Process of Producing a Composite Macrostructure of Organic and Inorganic Materials;” U.S. Pat. No. 4,983,573, J. D. Bolt, et al, “Process for making 90° K superconductors by impregnating cellulosic article with precursor solution;” U.S. Pat. No. 5,219,829, G. Bauer, et al, “Process and apparatus for the preparation of pulverulent metal oxides for ceramic compositions;” GB 2,260,538, P. Gant, “Porous ceramics;” U.S. Pat. No. 5,296,261, J. Bouet, et al, “Method of manufacturing a sponge-type support for an electrode in an electrochemical cell;” U.S. Pat. No. 5,338,334, Y. S. Zhen, et al, “Process for preparing submicron/nanosize ceramic powders from precursors incorporated within a polymeric foam;” and S. J. Powell and J. R. G. Evans, “The structure of ceramic foams prepared from polyurethane-ceramic suspensions,” Materials & Manufacturing Processes, 10(4):757 (1995). The focus of this art is directed to the preparation of either metal or metal oxide foams and/or particles. None of the disclosures of these aforementioned references mentions in situ solid phase formation via redox precipitation reaction from homogeneous solution as a formative method.

[0009] The prior art also discloses certain methods for fabricating, inorganic shaped bodies using natural, organic objects. These fabrication methods, however, are not without drawbacks which include cracking upon drying the green body and/or upon firing. To alleviate these problems, the fabrication processes typically involve controlled temperature and pressure conditions to achieve the desired end product. In addition, prior fabrication methods may include the additional steps of extensive material preparation to achieve proper purity, particle size distribution and orientation, intermediate drying and radiation steps, and sintering at temperatures above the range desired for employment in the present invention. For example, U.S. Pat. No. 5,298,205 issued to Hayes et. al. entitled “Ceramic Filter Process”, incorporated herein by reference, discloses a method of fabricating a porous ceramic body from an organic sponge saturated in an aqueous slurry comprised of gluten and particulate ceramic material fired at a temperature range from 1,100° to 1,300° C. Hayes teaches that the saturated sponge must be dehydrated prior to firing via microwave radiation, and includes a pre-soak heating step, and a hot pressing step.

[0010] While improvements have been made in materials synthesis and ceramic processing technology leading to porous ceramics and ceramic biomaterials, improved preparative methods, and the final products these methods yield, are still greatly desired. Generation of controlled porosity in ceramic biomaterials generally, and in calcium phosphate materials in particular, is crucial to the effective in vitro and in vivo use of these synthetic materials for regenerating human cells and tissues. This invention provides both novel, porous calcium phosphate materials and methods for preparing them. Methods relating to calcium phosphate-containing biomaterials, which exhibit improved biological properties, are also greatly desired despite the great efforts of others to achieve such improvements.

[0011] In particular, this invention provides such novel, porous calcium phosphate and other materials in composite forms, especially in shaped bodies. Thus, the benefits of these novel materials are now enhanced through combining into such shaped bodies areas of the novel materials along with areas or portions comprising other materials.

[0012] Accordingly, it is a principal object of this invention to provide improved inorganic, porous, shaped bodies, especially those formed of calcium phosphate.

[0013] Such shaped bodies having a plurality of portions, one of which comprises the novel, inorganic, porous materials of this invention are also provide by this invention.

[0014] Another object is to provide shaped bodies for surgical, orthopaedic, reconstructive and restorative uses.

[0015] A further object of the invention is to provide methods for forming such materials with improved yields, lower processing temperatures, greater compositional flexibility, and better control of porosity.

[0016] Yet another object provides materials with micro-, meso-, and macroporosity, as well as the ability to generate shaped porous solids having improved uniformity, biological activity, catalytic activity, and other properties.

[0017] Another object is to provide porous materials which are useful in the repair and/or replacement of bone in orthopaedic and dental procedures.

[0018] An additional object is to prepare a multiplicity of high purity, complex shaped objects, formed at temperatures below those commonly used in traditional firing methods.

[0019] Further objects will become apparent from a review of the present specification.

SUMMARY OF THE INVENTION

[0020] The present invention is directed to new inorganic bodies, especially controllably porous bodies, which can be formed into virtually any geometric shape. The novel preparative methods of the invention utilize redox precipitation chemistry or aqueous solution chemistry, which is described in pending U.S. patent application Ser. No. 08/784,439 assigned to the present assignee and, incorporated herein by reference. In accordance with certain preferred embodiments, the redox precipitation chemistry is utilized in conjunction with a sacrificial, porous cellular support, such as an organic foam or sponge, to produce a porous inorganic product which faithfully replicates both the bulk geometric form as well as the macro-, meso-, and microstructure of the precursor organic support. The aqueous solution, because of its unique chemistry, has a high solids equivalent, yet can essentially be imbibed fully into and infiltrate thoroughly the microstructure of the sacrificial organic precursor material. This extent of infiltration allows the structural details and intricacies of the precursor organic foam materials to be reproduced to a degree heretofore unattainable. This great improvement can result in porous minorganic materials having novel microstructural features and sufficient robustness to be handled as coherent bodies of highly porous solid.

[0021] The invention also gives rise to porous inorganic materials having improved compositional homogeneity, multiphasic character, and/or modified crystal structures at temperatures far lower than those required in conventional formation methods. In addition, the invention also gives rise to porous inorganic composites comprising mineral scaffolds strengthened and/or reinforced with polymers, especially film-forming polymers, such as gelatin.

[0022] The present invention is also directed to composite shaped bodies comprising two or more portions. One of the portions is the reaction product of a metal cation and an oxidizing agent together with a precursor anion oxidizable by the oxidizing agent. The reaction is one which gives rise to at least on gaseous product. Another portion of the composite shaped bodies of the invention is another solid. Such solid may be any of a wide range of materials such as metal, especially titanium, stainless steel and other surgical metals, ceramic, glass, polymer or other generally hard material. The composite shaped bodies are ideally suited for surgical use, especially in orthopaedics and in reconstructive and restorative surgery. The porous materials forming one portion of the composite bodies of the invention are high compatible with such surgical use and can give rise to osteogenesis or osteostimulation in some cases. This is especially true of calcium phosphate materials.

[0023] The new paradigm created by this invention is facilitated by a definition of terms used in the description of embodiments. The general method starts with infiltrant solutions produced from raw materials described herein as salts, aqueous solutions of salts, stable hydrosols or other stable dispersions, and/or inorganic acids. The sacrificial, porous organic templates used in some embodiments may be organic foams, cellular solids and the like, especially open-cell hydrophilic material which can imbibe the aqueous infiltrant solutions. Both the precursor organic templates, as well as the inorganic replicas produced in accordance within this invention, display a porosity range of at least 3 orders of magnitude. This range of porosity can be described as macro-, meso- and microporous. Within the scope of this invention, macroporosity is defined as having a pore diameter greater than or equal to 100 microns, mesoporosity is defined as having a pore diameter less than 100 microns but greater than or equal to 10 microns, and microporosity is defined as having a pore diameter less than 10 microns.

[0024] In addition to the controlled macro-, meso- and microporosity ranges, inorganic shaped bodies have been fabricated possessing pore volumes of at least about 30%. In preferred embodiments, pore volumes of over 50% have been attained and pore volumes in excess of 70% or 80% are more preferred. Materials having macro-, meso- and microporosity together with pore volumes of at least about 90% can be made as can those having pore volumes over 92% and even 94%. In some cases, pore volumes approaching 95% have been ascertained in products which, nevertheless, retain their structural integrity and pore structure.

[0025] The phases produced by the methods of this invention [Redox Precipitation Reaction (RPR) and Hydrothermal PROCESSING (HYPR)] initially are intermediate or precursor minerals, which can be easily converted to a myriad of pure and multiphasic minerals of previously known and, in some cases, heretofore undefined stoichiometry, generally via a thermal treatment under modest firing regimens compared to known and practiced conventional art.

[0026] In accordance with certain embodiments of the present invention, methods are provided for the restoration of bony tissue. In this regard, an area of bony tissue requiring repair as a result of disease, injury, desired reconfiguration and the like, is identified and preferably measured. A block of porous calcium phosphate material can be made to fit the dimensions of the missing or damaged bony tissue and implanted in place by itself or in conjunction with biocompatible bonding material compositions such as those disclosed in U.S. Pat. No. 5,681,872 issued in the name of E. M. Erbe on Oct. 28, 1997 and incorporated herein by reference. The calcium phosphate material can also be used as a “sleeve” or form for other implants, as a containment vessel for the bone grafting material which is introduced into the sleeve for the repair, and in many other contexts.

[0027] A major advantage of the restoration is that after polymerization, it has a significant, inherent strength, such that restoration of load-bearing bony sites can be achieved. While immobilization of the effected part will likely still be required, the present invention permits the restoration of many additional bony areas than has been achievable heretofore. Further, since the porous calcium phosphate scaffolding material of the present invention is biocompatible and, indeed, bioactive, osteogenesis can occur. This leads to bone infiltration and replacement of the calcium phosphate matrix with autologous bone tissue.

[0028] The calcium phosphate scaffolding material of the present invention may also be made into shaped bodies for a variety of uses. Thus, orthopaedic appliances such as joints, rods, pins, or screws for orthopaedic surgery, plates, sheets, and a number of other shapes may be formed from the material in and of itself or used in conjunction with conventional appliances that are known in the art. Such hardened compositions can be bioactive and can be used, preferably in conjunction with hardenable compositions in accordance with the present invention in the form of gels, pastes, or fluids, in surgical techniques. Thus, a screw or pin can be inserted into a broken bone in the same way that metal screws and pins are currently inserted, using conventional bone cements or restoratives in accordance with the present invention or otherwise. The bioactivity of the present hardenable materials give rise to osteogenesis, with beneficial medical or surgical results.

[0029] The methods of the invention are energy efficient, being performed at relatively low temperature; have high yields; and are amenable to careful control of product shape, macro- and microstructure, porosity, and chemical purity. Employment as bioactive ceramics is a principal, anticipated use for the materials of the invention, with improved properties being extant. Other uses of the porous minerals and processes for making the same are also within the spirit of the invention.

[0030] The present invention also provides exceptionally fine, uniform powders of inorganic materials. Such powders have uniform morphology, uniform composition and narrow size distribution. They may be attained through the comminution of shaped bodies in accordance with the invention and have wide utility in chemistry, industry, medicine and otherwise.

BRIEF DESCRIPTION OF THE DRAWINGS

[0031] FIG. 1 depicts an aggregated physical structure of an RPR generated, multiphasic β-tricalcium phosphate (β-TCP)+type-B carbonated apatite (c-HAp) [β-Ca3(PO4)2+Ca5(PO 4 )3-x(CO3)x(OH)] prepared in accordance with one embodiment of this invention. The entire agglomerated particle is approximately 10 μm, and the individual crystallites are typically less than about 1 μm and relatively uniform in particle size and shape.

[0032] FIG. 2 represents assembled monetite, CaHPO 4 particles formed from a hydrothermal precipitation in accordance with certain methods taught by this invention. The entire particle assemblage is typically about 30 μm and is comprised of relatively uniformly rectangular cubes and plate-like crystallites of various sizes and aspect ratios.

[0033] FIG. 3 illustrates a water purification disk that is comprised of the porous inorganic material of the present invention and is contained within an exterior housing for filtration or separation purposes.

[0034] FIG. 4 illustrates shaped bodies of porous inorganic material of the present invention used as a catalyst support within a hot gas reactor or diffusor.

[0035] FIG. 5 illustrates shaped bodies of porous calcium phosphate material of the present invention implanted at several sites within a human femur for cell seeding, drug delivery, protein adsorption, or growth factor scaffolding purposes.

[0036] FIGS. 6 A and FIG. 6B illustrate one embodiment of porous calcium phosphate scaffolding material of the present invention used as an accommodating sleeve in which a tooth is screwed, bonded, cemented, pinned, anchored, or otherwise attached in place.

[0037] FIGS. 7 and 7 A illustrate another embodiment of the porous calcium phosphate scaffolding material of the present invention used as a cranio-maxillofacial, zygomatic reconstruction and mandibular implant.

[0038] FIGS. 8A and 8B illustrate one embodiment of the porous calcium phosphate scaffolding material of the present invention shaped into a block form and used as a tibial plateau reconstruction that is screwed, bonded, cemented, pinned, anchored, or otherwise attached in place.

[0039] FIG. 9 illustrates an embodiment of the porous calcium phosphate scaffolding material of the present invention shaped into a block or sleeve form and used for the repair or replacement of bulk defects in metaphyseal bone, oncology defects or screw augmentation.

[0040] FIGS. 10A and 10B illustrate an embodiment of the porous calcium phosphate scaffolding material of the present invention shaped into a sleeve form and used for impaction grafting to accommodate an artificial implant said sleeve form being screwed, bonded, pinned or otherwise attached in place.

[0041] FIG. 11 is an X-ray diffraction (XRD) plot of a pulverized sample of porous calcium phosphate material fired at 500° C. in accordance with one embodiment of this invention. The sample consists of a biphasic mixture of whitlockite Ca 3 (PO 4 ) 2 (PDF 09-0169) and hydroxyapatite Ca 5 (PO 4 ) 3 (OH) (PDF 09-0432).

[0042] FIG. 12 is a 50×magnification scanning electron micrograph of a virgin cellulose sponge material used to prepare several of the embodiments of this invention.

[0043] FIG. 13 is a 100×magnification scanning electron micrograph of porous calcium phosphate material fired at 500° C. in accordance with one embodiment of this invention.

[0044] FIG. 14 is an X-ray diffraction (XRD) plot of a pulverized sample of porous calcium phosphate material fired at 1100° C. in accordance with one embodiment of this invention. The sample consists of whitlockite Ca 3 (PO 4 ) 2 (PDF 09-0169).

[0045] FIG. 15 is an X-ray diffraction (XRD) plot of a pulverized sample of porous calcium phosphate material fired at 1350° C. in accordance with one embodiment of this invention. The sample consists of whitlockite Ca 3 (PO 4 ) 2 (PDF 09-0169).

[0046] FIG. 16 is an X-ray diffraction (XRD) plot of a pulverized sample of porous calcium phosphate material fired at 800° C. in accordance with one embodiment of this invention. The sample consists of calcium pyrophosphate, Ca 2 P 2 O 7 (PDF 33-0297).

[0047] FIG. 17 is an X-ray diffraction (XRD) plot of a pulverized sample of porous zinc phosphate material fired at 500° C. in accordance with one embodiment of this invention. The sample consists of zinc phosphate, Zn 3 (PO 4 ) 2 (PDF 30-1490).

[0048] FIG. 18 is an X-ray diffraction (XRD) plot of a pulverized sample of porous neodymium phosphate material fired at 500° C. in accordance with one embodiment of this invention. The sample consists of neodymium phosphate, NdPO 4 (PDF 25-1065).

[0049] FIG. 19 is an X-ray diffraction (XRD) plot of a pulverized sample of porous aluminum phosphate material fired at 500° C. in accordance with one embodiment of this invention. The sample consists of aluminum phosphate, AIPO 4 (PDF 11-0500).

[0050] FIG. 20 is a 23×magnification scanning electron micrograph depicting the macro- and meso-porosity of porous calcium phosphate material fired at 500° C. and reinforced with gelatin in accordance with one embodiment of this invention.

[0051] FIG. 21 is a 25×magnification scanning electron micrograph of sheep trabecular bone for comparative purposes.

[0052] FIG. 22 is a 2000×magnification scanning electron micrograph of the air-dried gelatin treated inorganic sponge depicted in FIG. 20 which exhibits meso- and microporosity in the calcium phosphate matrix. FIGS. 20 and 22 , together, demonstrate the presence of macro-, meso-, and microporosity simultaneously in a highly porous product.

[0053] FIG. 23 is an X-ray diffraction (XRD) plot of a pulverized sample of the ash remaining after firing at 500° C. of the virgin cellulose sponge starting material used to prepare several of the embodiments of this invention. The ash sample consists of a biphasic mixture of magnesium oxide, MgO (major) (PDF 45-0946) and sodium chloride, NaCl (minor) (PDF 05-0628).

[0054] FIG. 24 is a 20×magnification scanning electron micrograph of a virgin cellulose sponge starting material, expanded from its compressed state, used to prepare several of the embodiments of this invention.

[0055] FIG. 25 is a 20×magnification scanning electron micrograph of porous calcium phosphate material fired at 800° C. and reinforced with gelatin in accordance with one embodiment of this invention.

[0056] FIG. 26 depicts a calcium phosphate porous body, produced in accordance with one embodiment of this invention partially wicked with blood.

[0057] FIG. 27 shows a cylinder of calcium phosphate prepared in accordance with one embodiment of this invention, implanted into the metaphyseal bone of a canine.

[0058] FIG. 28 is an X-ray diffraction plot of a pulverized sample of a cation substituted hydroxyapatite material processed in accordance with the methods described in this invention.

[0059] FIG. 29 depicts a synthetic cortical vertebral ring inserted between a pair of vertebrae in a spine. The injection of hardenable material, such as bone cement, into a port in the cortical ring is shown.

[0060] FIG. 30 is a lateral view of a synthetic cortico-cancellous vertebral ring or interbody fusion device. The composite nature of the device is shown to comprise first and second portions comprising different materials.

[0061] FIGS. 31 through 34 all depict spinal surgical applications with vertebrae depicted in phantom, 220 .

[0062] FIG. 31 shows one embodiment of a synthetic cortical bone dowel in place. The dowel has a plurality of ports, some of which are shown 224 .

[0063] FIG. 32 depicts another bone dowel for spinal fusion.

[0064] FIG. 33 shows a synthetic cortical interbody vertebral defect filling form.

[0065] FIG. 34 shows a cross section of a spinal fusion employing a shaped body of the invention potted in hardenable material.

[0066] FIGS. 35 a, 35 b and 35 c depict synthetic cortical vertebral spacers or interbody devices. FIGS. 35 b and 35 c are in the shape of rings.

[0067] FIGS. 36 a through c depict synthetic cortical bone dowels or interbody devices.

[0068] FIG. 37 is another form of cortical spacer.

[0069] FIG. 38 is of a synthetic cancellous bone dowel.

[0070] FIG. 39 is a synthetic cortical vertebral interbody device.

[0071] FIGS. 40 a, and 40 c are of synthetic cortico-cancellous defect filling forms for bone restoration. FIG. 40 b shows a cancellous defect filling form.

[0072] FIGS. 41 a and 41 b are drawn to bone dowels.

[0073] FIG. 42 is a synthetic cortical ring

[0074] FIG. 43 is a cortical rod for orthopaedic restoration

[0075] FIG. 44 is a synthetic cortico-cancellous “tri-cortical” device

[0076] FIG. 45 depicts a cortico-cancellous “crouton” for orthopaedic surgery.

[0077] FIG. 46 is a “match stick” orthopaedic surgical splint.

[0078] FIG. 47 a and 47 b are cortical struts for surgical use.

[0079] FIGS. 48, 49 , 50 a and 50 b are cortical rings.

[0080] FIG. 51 depicts an artificial femur head for reconstructive surgery.

[0081] FIG. 52 is an artificial bone portion

[0082] FIG. 53 is a strut or tube for reconstruction.

[0083] FIG. 54 is an acetabular/pelvic form for orthopaedic reconstruction.

[0084] FIG. 55 a and b depict insertion of a femoral hip dowel into a femur.

[0085] FIGS. 56 a through d are different forms of dowels for orthopaedic use.

DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS

[0086] In accordance with this invention, composite shaped bodies are provided which are useful, e.g. in orthopaedic and other surgery. The bodies have a first portion which is a solid and which is attached to, adhered to, coformed with or in contact with a second portion. The second portion is reaction product of a blend comprising at least one metal cation at least one oxidizing agent; and at least one precursor anion oxidizable by said oxidizing agent to form an oxoanion. The reaction gives rise to at least one gaseous product and is generally of the type of reaction known as oxidation-reduction reactions. This results in what is termed an RPR-derived material. The resulting composite shaped bodies may be formed into nearly any shape, including shapes usefuil in orthopaedic and other surgery, especially when the RPR-derived material is a calcium phosphate.

[0087] The RPR-derived material is usually arrived at in two stages. Thus, a precursor mineral is formed from an immediate oxidation-reduction reaction, and then that material is consolidated or transformed into a final calcium phosphate or other material. In accordance with the present invention, methods are provided for preparing shapes comprising an intermediate precursor mineral of at least one metal cation and at least one oxoanion. These methods comprise preparing an aqueous solution of the metal cation and at least one oxidizing agent. The solution is augmented with at least one soluble precursor anion oxidizable by said oxidizing agent to give rise to the precipitant oxoanion. The oxidation-reduction reaction thus contemplated is conveniently initiated by heating the solution under conditions of temperature and pressure effective to give rise to said reaction. In accordance with preferred embodiments of the invention, the oxidation-reduction reaction causes at least one gaseous product to evolve and the desired intermediate precursor mineral to precipitate from the solution.

[0088] The intermediate precursor mineral thus prepared can either be used “as is” or can be treated in a number of ways. Thus, it may be heat treated in accordance with one or, more paradigms to give rise to a preselected crystal structure or other preselected morphological structures therein. In accordance with preferred embodiments, the oxidizing agent is nitrate ion and the gaseous product is a nitrogen oxide, generically depicted as NO x(g) . It is preferred that the precursor mineral provided by the present methods be substantially homogeneous. It is also preferred for many embodiments that the temperature reached by the oxidation-reduction reaction not exceed about 150° C. unless the reaction is run under hydrothermal conditions or in a pressure vessel.

[0089] In accordance with other preferred embodiments, the intermediate precursor mineral provided by the present invention is a calcium phosphate. It is preferred that such mineral precursor comprise, in major proportion, a solid phase which cannot be identified singularly with any conventional crystalline form of calcium phosphate. At the same time, the calcium phosphate mineral precursors of the present invention are substantially homogeneous and do not comprise a physical admixture of naturally occurring or conventional crystal phases.

[0090] In accordance with preferred embodiments, the low temperature processes of the invention lead to the homogeneous precipitation of high purity powders from highly concentrated solutions. Subsequent modest heat treatments convert the intermediate material to e.g. novel monophasic calcium phosphate minerals or novel biphasic β-tricalcium phosphate (β-TCP)+type-B, carbonated apatite (c-HAp) [β-Ca 3 (PO 4 ) 2 +Ca 5 (PO 4 ) 3-x (CO 3 ) x (OH)] particulates.

[0091] In other preferred embodiments, calcium phosphate salts are provided through methods where at least one of the precursor anions is a phosphorus oxoanion, preferably introduced as hypophosphorous acid or a soluble alkali or alkaline-earth hypophosphite salt. For the preparation of such calcium phosphates, it is preferred that the initial pH be maintained below about 3, and still more preferably below about 1.

[0092] The intermediate precursor minerals prepared in accordance with the present methods are, themselves, novel and not to be expected from prior methodologies. Thus, such precursor minerals can be, at once, non-stoichiometric and possessed of uniform morphology.

[0093] It is preferred in connection with some embodiments of the present invention that the intermediate precursor minerals produced in accordance with the present methods be heated, or otherwise treated, to change their properties. Thus, such materials may be heated to temperatures as low as 300° C. up to about 800° C. to give rise to certain beneficial transformations. Such heating will remove extraneous materials from the mineral precursor, will alter its composition and morphology in some cases, and can confer upon the mineral a particular and preselected crystalline structure. Such heat treatment can be to temperatures which are considerably less than those used conventionally in accordance with prior methodologies to produce end product mineral phases. Accordingly, the heat treatments of the present invention do not, necessarily, give rise to the “common” crystalline morphologies of monetite, dicalcium or tricalcium phosphate, tetracalcium phosphate, etc., but, rather, they can lead to new and unobvious morphologies which have great utility in the practice of the present invention.

[0094] The present invention is directed to the preparation, production and use of shaped bodies of inorganic materials. It will be appreciated that shaped bodies can be elaborated in a number of ways, which shaped bodies comprise an inorganic material. A preferred method for giving rise to the shaped bodies comprising minerals is through the use of subject matter disclosed in U.S. Ser. No. 08/784,439 filed Jan. 16, 1997, assigned to the assignee of the present invention and incorporated herein by reference. In accordance with techniques preferred for use in conjunction with the present invention, a blend of materials are formed which can react to give rise to the desired mineral, or precursor thereof, at relatively low temperatures and under relatively flexible reaction conditions. Preferably, the reactive blends thus used include oxidizing agents and materials which can be oxidized by the oxidizing agent, especially those which can give rise to a phosphorus oxoanion. Many aspects of this chemistry are described hereinafter in the present specification. It is to be understood, however, that such reactive blends react at modest temperatures under modest reaction conditions, usually through the evolution of a nitrogen oxide gas, to give rise to the minerals desired for preparation or to materials which may be transformed such as through heating or sintering to form such minerals. A principal object of the present invention is to permit such minerals to be formed in the form of shaped bodies.

[0095] It will be appreciated that preferred compositions of this invention exhibit high degrees of porosity. It is also preferred that the porosity occur in a wide range of effective pore sizes. In this regard, persons skilled in the art will appreciate that preferred embodiments of the invention have, at once, macroporosity, mesoporosity and microporosity. Macroporosity is characterized by pore diameters greater than about 100 μm. Mesoporosity is characterized by pore diameters between about 100 and 10 μm, while microporosity occurs when pores have diameters below about 10 μm. It is preferred that macro-, meso- and microporosity occur simultaneously in products of the invention. It is not necessary to quantify each type of porosity to a high degree. Rather, persons skilled in the art can easily determine whether a material has each type of porosity through examination, such as through the preferred method of scanning electron microscopy. While it is certainly true that more than one or a few pores within the requisite size range are needed in order to characterize a sample as having a substantial degree of that particular form of porosity, no specific number or percentage is called for. Rather, a qualitative evaluation by persons skilled in the art shall be used to determine macro-, meso- and microporosity.

[0096] It is preferred that the overall porosity of materials prepared in accordance with this invention be high. This characteristic is measured by pore volume, expressed as a percentage. Zero percent pore volume refers to a fully dense material, which, perforce, has no pores at all. One hundred percent pore volume cannot meaningfully exist since the same would refer to “all pores” or air. Persons skilled in the art understand the concept of pore volume, however and can easily calculate and apply it. For example, pore volume may be determined in accordance with W. D. Kingery, Introduction to Ceramics, 1960 p. 416 (Wiley, 1060), who provides a formula for determination of porosity. Expressing porosity as a percentage yields pore volume. The formula is: Pore Volume=(1−f p ) 100%, where f p is fraction of theoretical density achieved.

[0097] Pore volumes in excess of about 30% are easily achieved in accordance with this invention while materials having pore volumes in excess of 50 or 60% are also routinely attainable. It is preferred that materials of the invention have pore volumes of at least about 75%. More preferred are materials having pore volumes in excess of about 85%, with 90% being still more preferred. Pore volumes greater than about 92% are possible as are volumes greater than about 94%. In some cases, materials with pore volumes approaching 95% can be made in accordance with the invention. In preferred cases, such high pore volumes are attained while also attaining the presence of macro- meso- and microporosity as well as physical stability of the materials produced. It is believed to be a great advantage to be able to prepare inorganic shaped bodies having macro-, meso- and microporosity simultaneously with high pore volumes as described above.

[0098] It has now been found that such shaped bodies may be formed from minerals in this way which have remarkable macro- and microstructures. In particular, a wide variety of different shapes can be formed and bodies can be prepared which are machinable, deformable, or otherwise modifiable into still other, desired states. The shaped bodies have sufficient inherent physical strength allowing that such manipulation can be employed. The shaped bodies can also be modified in a number of ways to increase or decrease their physical strength and other properties so as to lend those bodies to still further modes of employment. Overall, the present invention is extraordinarily broad in that shaped mineral bodies may be formed easily, inexpensively, under carefully controllable conditions, and with enormous flexibility. Moreover, the microstructure of the materials that can be formed from the present invention can be controlled as well, such that they may be caused to emulate natural bone, to adopt a uniform microstructure, to be relatively dense, relatively porous, or, in short, to adopt a wide variety of different forms. The ability to control in a predictable and reproducible fashion the macrostructure, microstructure, and mineral identity of shaped bodies in accordance with the present invention under relatively benign conditions using inexpensive starting materials lends the technologies of the present invention to great medical, chemical, industrial, laboratory, and other uses.

[0099] In accordance with certain preferred embodiments of the present invention, a reactive blend in accordance with the invention is caused to be imbibed into a material which is capable of absorbing it. It is preferred that the material have significant porosity, be capable of absorbing significant amounts of the reactive blend via capillary action, and that the same be substantially inert to reaction with the blend prior to its autologous oxidation-reduction reaction. It has been found to be convenient to employ sponge materials, especially cellulose sponges of a kind commonly found in household use for this purpose. Other sponges, including those which are available in compressed form such as Normandy sponges, are also preferred in certain embodiments. The substrate used to imbibe the reactive blend, however, are not limited to organic materials and can include inorganic materials such as fiberglass.

[0100] The sponges are caused to imbibe the reactive blend in accordance with the invention and are subsequently, preferably blotted to remove excess liquid. The reactive blend-laden sponge is then heated to whatever degree may be necessary to initiate the oxidation-reduction reaction of the reactive blend. Provision is generally made for the removal of by-product noxious gases, chiefly nitrogen oxide gases, from the site of the reaction. The reaction is exothermic, however the entire reacted body does not generally exceed a few hundred degrees centigrade. In any event, the reaction goes to completion, whereupon what is seen is an object in the shape of the original sponge which is now intimately comprised of the product of the oxidation reduction reaction. This material may either be the finished, desired mineral, or may be a precursor from which the desired product may be obtained by subsequent PROCESSING.

[0101] Following the initial oxidation-reduction reaction, it is convenient and, in many cases, preferred to heat treat the reacted product so as to eliminate the original sponge. In this way, the cellulosic component of the sponge is pyrolyzed in a fugitive fashion, leaving behind only the mineral and in some cases, a small amount of ash. The resulting shaped body is in the form of the original sponge and is self-supporting. As such, it may be used without further transformation or it may be treated in one or more ways to change its chemical and or physical properties. Thus, the shaped body following the oxidation-reduction reaction, can be heat treated at temperatures of from about 250° C. to about 1400° C., preferably from 500° C. to about 1000° C., and still more preferably from about 500° C. to about 800° C. Thus, a precursor mineral formed from the oxidation-reduction reaction may be transformed into the final mineral desired for ultimate use. A number of such transformations are described in the examples to the present application and still others will readily occur to persons skilled in the art.

[0102] It will be appreciated that temperatures in excess of 250° C. may be employed in initiating the oxidation-reduction reaction and, indeed, any convenient temperature may be so utilized. Moreover, methods of initiating the reaction where the effective temperature is difficult or impossible to determine, such a microwave heating, may, also be employed. The preferred procedures, however, are to employ reaction conditions to initiate, and propagate if necessary, the reaction are below the temperature wherein melting of the products occur. This is in distinction with conventional glass and ceramic processing methods.

[0103] The shaped bodies thus formed may be used in a number of ways directly or may be further modified. Thus, either the as-formed product of the oxidation-reduction reaction may be modified, or a resulting, transformed mineral structure may be modified, or both. Various natural and synthetic polymers, pre-polymers, organic materials, metals and other adjuvants may be added to the inorganic structures thus formed. Thus, wax, glycerin, gelatin., pre-polymeric materials such as precursors to various nylons, acrylics, epoxies, polyalkylenes, and the like, may be caused to permeate all or part of the shaped bodies formed in accordance with the present invention. These may be used to modify the physical and chemical nature of such bodies. In the case of polymers, strength modifications may easily be obtained. Additionally, such materials may also change the chemical nature of the minerals, such as by improving their conductivity, resistance to degradation, electrolytic properties, electrochemical properties, catalytic properties, or otherwise. All such modifications are contemplated by the present invention.

[0104] As will be appreciated, the shaped bodies prepared in accordance with the present invention may be formed in a very large variety of shapes and structures. It is very easy to form cellulose sponge material into differing shapes such as rings, rods, screw-like structures, and the like. These shapes, when caused to imbibe a reactive blend, will give rise to products which emulate the original shapes. It is also convenient to prepare blocks, disks, cones, frustrums or other gross shapes in accordance with the present invention which shapes can be machined, cut, or otherwise manipulated into a final desired configuration. Once this has been done, the resulting products may be used as is or may be modified through the addition of gelatin, wax, polymers, and the like, and used in a host of applications.

[0105] When an inherently porous body such as a sponge is used as a substrate for the imbibition of reactive blend and the subsequent elaboration of oxidation-reduction product, the resulting product replicates the shape and morphology of the sponge. Modifications in the shape of the sponge, and in its microstructure can give rise to modifications in at least the intermediate structure and gross structures of the resulting products. It has been found, however, that the microstructure of shaped bodies prepared in accordance with the present invention frequently include complex and highly desirable features. Thus, on a highly magnified scale, microstructure of materials produced in accordance with the present invention can show significant microporosity. In several embodiments of the present invention, the microstructure can be custom-tailored based upon the absorbent material selected as the fugitive support. One particular embodiment, which used a kitchen sponge as the absorbent material, exhibited a macro- and microstructure similar to the appearance of ovine trabecular bone. This highly surprising, yet highly desirable result gives rise to obvious benefits in terms of the replication of bony structures and to the use of the present invention in conjunction with the restoration of bony tissues in animals and especially in humans.

[0106] Other macro- and microstructures may be attained through the present invention, however. Thus, through use of the embodiments of the present invention, great diversity may be attained in the preparation of mineral structures not only on a macroscopic but also on a microscopic level. Accordingly, the present invention finds utility in a wide variety of applications. Thus, the shaped bodies may be used in medicine, for example for the restoration of bony defects and the like. The materials may also be used for the delivery of medicaments internal to the body. In this way, the porosity of a material formed in accordance with the invention may be all or partially filled with another material which either comprises or carries a medicament such as a growth hormone, antibiotic, cell signaling material, or the like. Indeed, the larger porous spaces within some of the products of the present invention may be used for the culturing of cells within the human body. In this regard, the larger spaces are amenable to the growth of cells and can be permeated readily by bodily fluids such as certain blood components. In this way, growing cells may be implanted in an animal through the aegis of implants in accordance with the present invention. These implants may give rise to important biochemical or therapeutic or other uses.

[0107] The present invention can call for the use of therapeutic materials. Replicated bone marrow or other types of bioengineered bone marrow material can be used in this invention. Therapeutic materials can also be used for the delivery of healing materials, such as medicaments, internal to the body. Such medicaments can be growth hormones, antibiotics, or cell signals. Medicaments also may include steroids, analgesics, or fertility drugs. Exemplary therapeutic materials include signaling molecules under the Transforming Growth Factor (TGF) Superfamily of proteins, specifically proteins under the TGF-beta (TGF-β), Osteogenic Protein (OP)/Bone Morphogenic Protein (BMP), VEGF (VEGF-1 and VEGF-2 proteins) and Inhibin/activtin (Inhibin-beta A, Inhibin-beta B, Inhibin-alpha, and MIS proteins) subfamilies. Most preferably, the exemplary therapeutic materials are proteins under the TGF-β and OP/BMP subfamilies. The TGF-β subfamily includes the proteins Beta-2, Beta-3, Beta-4 (chicken), Beta-1, Beta-5 (xenopus) and HIF-1 alpha. The OP/BMP subfamily includes the proteins BMP-2, BMP-4, DPP, BMP-5, Vgr-1, OP-1/BMP-7, Drosophila 60A, GDF-1, Xenopus Vg-1 and BMP-3. Representative proteins of these types include: OP-1/rhBMP-7, rhBMP-2, IGF-1 (Insulin-like Growth Factor-1), TGF beta, MP52. Other proteins, genes and cells outside the TGF Superfamily may also be included in the exemplary types of therapeutic materials to be used in conjunction with the present invention. These other proteins, genes and cells include PepGen P-15, LMP-1 (LIM Mineralized Protein-I gene), Chrysalin TP 508 Synthetic Peptide, GAM (parathyroid hormone), rhGDF-5, cell lines and FGF (Fibroblast Growth Factor) such as BFGF (Basic Fibroblast Growth Factor), FGF-A (Fibroblast Growth Factor Acidic), FGFR (Fibroblast Growth Factor Receptor) and certain cell lines such as osteosarcoma cell lines. The therapeutic materials to be used with the present invention material may also be combinations of those listed above. Such mixtures include products like Ne-Osteo GFm (growth factor mixture), or mixtures of growth factors/proteins/genes/cells produced by devices such as AGF (Autologous Growth Factor), Symphony Platelet Concentrate System, and the like.

[0108] The invention finds great utility in chemistry as well. Shaped bodies formed from the present invention may be formed to resemble saddles, rings, disks, honeycombs, spheres, tubes, matrixes, and, in short, a huge array of shapes, which shapes may be used for engineering purposes. Thus, such shapes may be made from minerals which incorporate catalytic components such as rare earths, precious and base metals, palladium, platinum, Raney nickel and the like for catalytic use. These shapes may also be used for column packing for distillation and other purposes. Indeed, the shapes may be capable of serving a plurality of uses at once, such as being a substrate for refluxing while acting as a catalyst at the same time.

[0109] The bodies of the present invention will also be suitable for chromatography and other separation and purification techniques. Thus, they may serve as substrates for mobile phases in the same way that a capillary suspends a gelatinous material for capillary gel electrophoresis.

[0110] The present invention also provides filtration media. As is apparent, the porous structures of the present invention may serve as filters. Due to the ability to formulate these shaped bodies in a wide variety of carefully controlled ways, some unique structures may be attained. Thus, an anigotropic membrane, as known to persons of ordinary skill in the art, and frequently referred to as a “Michaels” membrane may be used for the imbibation of reactive blend in accordance with the invention. Following redox reaction and removal of the membranous material as a fugitive phase, the resulting inorganic structure is also anisotropic. It is thus possible to utilize materials and shaped bodies in accordance with the present invention as an anisotropic but inorganic filtration media. Since it is also possible to include a number of inorganic materials therein, such filters may be caused to be inherently bacteriostatic and non-fouling. It has been shown, heretofore, that anisotropic membranes such as polysulfone and other membranes are capable of nurturing and growing cells for the purposes of delivering cellular products into a reaction screen. It is now possible to accomplish the same goals using wholly inorganic structures prepared in accordance with this invention.

[0111] In addition to the foregoing, it is possible to prepare and modify shaped bodies in accordance with the present invention in a variety of other ways. Thus, the shaped bodies may be coated, such as with a polymer. Such polymers may be any of the film forming polymers or otherwise and may be used for purposes of activation, conductivity, passivation, protection, or other chemical and physical modification. The bodies may also be contacted with a “keying agent” such as a silane, or otherwise to enable the grafting of different materials onto the surface of the polymer.

[0112] The shaped bodies of the invention may also be used for the growth of oligomers on their surfaces. This can be done in a manner analogous to a Merrifield synthesis, an oligonucleotide synthesis or otherwise. Such shaped bodies may find use in conjunction with automated syntheses of such oligomers and may be used to deliver such oligomers to the body of an animal, to an assay, to a synthetic reaction vessel, or otherwise. Since the mineral composition of the shaped bodies of this invention may be varied so widely, it is quite suitable to the elaboration of oligomers as suggested here and above. Grafting of other inorganic materials, silanes, especially silicones and similar materials, is a particular feature of the present invention. The grafting reactions, keying reactions, oligomer extension reactions and the like are all known to persons skilled in the art and will not be repeated here. Suffice it to say that all such reactions are included within the scope of the present invention.

[0113] The shaped bodies of the invention may also be coated through surface layer deposition techniques such as plasma coating, electroless plating, chemical vapor deposition (CVD), physical vapor deposition (PVD), or other methods. In such a way, the surface structure of the shaped bodies may be modified in carefully controlled ways for catalytic, electronic, and other purposes. The chemistry and physics of chemical vapor deposition and other coating techniques are known to persons of ordinary skill in the art whose knowledge is hereby assumed.

[0114] In accordance with other embodiments of the invention, the shaped bodies produced hereby may be comminuted to yield highly useful and unique powder materials finding wide utility. Thus, shaped bodies may be crushed, milled, etc. and preferably classified or measured, such as with a light scattering instrument, to give rise to fine powders. Such powders are very small and highly uniform, both in size, shape and chemical composition. Particles may be prepared having particle size number means less than about 0.1 μm or 100 nanometers. Smaller mean sized may also be attained. Thus, this invention provides highly uniform inorganic materials in powder form having particle sizes, measured by light scattering techniques such that the number mean size is between about 0.1 and 5.0 μm. Particle sizes between about 0.5 and 2.0 μm may also be attained. It may, in some embodiments, be desired to classify the powders in order to improve uniformity of size.

[0115] The morphology of the particles is highly uniform, deriving, it is thought, from the microporosity of the shaped bodies from which they arise. The particles are also highly uniform chemically. Since they arise from a chemical reaction from a fully homogenous solution, such uniformity is much greater than is usually found in glass or ceramic melts.

[0116] Particle size number means are easily determined with a Horiba LA-910 instrument. Number means refers to the average or mean number of particles having the size or size range in question.

[0117] Such powders are very useful, finding use in cosmetics, pharmaceuticals, excipients, additives, pigments, fluorescing agents, fillers, flow control agents, thixotropic agents, materials processing, radiolabels, and in may other fields of endeavor. For example, a molded golf ball may easily be made such as via the processes of Bartsch, including a calcium phosphate powder of this invention admixed with a crosslinked acrylic polymer system.

[0118] In conjunction with certain embodiments of the present invention, shaping techniques are employed on the formed, shaped bodies of the present invention. Thus, such bodies may be machined, pressed, stamped, drilled, lathed, or otherwise mechanically treated to adopt a particular shape both externally and internally. As will be appreciated, the internal microstructure of the bodies of the present invention can be altered thru the application of external force where such modifications are desired. Thus, preforms may be formed in accordance with the invention from which shapes may be cut or formed. For example, an orthopaedic sleeve for a bone screw may be machined from a block of calcium phosphate made hereby, and the same tapped for screw threads or the like. Carefully controllable sculpting is also possible such that precisely-machined shapes may be made for bioimplantation and other uses.

[0119] While many of the present embodiments rely upon the imbibation of reactive blends by porous, organic media such as sponges and the like, it should be appreciated that many other ways of creating shaped bodies in accordance with this invention also exist. In some of these embodiments, addition of materials, either organic or inorganic, which serve to modify the characteristic of the reactive blend may be beneficial. As an example of this, flow control agents may be employed. Thus, it may be desirable to admix a reactive blend in accordance with the invention together with a material such as a carboxymethyl or other cellulose or another binding agent to give rise to a paste or slurry. This paste or slurry may then be formed and the oxidation reduction reaction initiated to give rise to particular shapes. For example, shaped bodies may be formed through casting, extrusion, foaming, doctor blading, spin molding, spray forming, and a host of other techniques. It is possible to extrude hollow shapes in the way that certain forms of hollow pasta are extruded. Indeed, machinery useful for the preparation of certain food stuffs may also find beneficial use in conjunction with certain embodiments of the present invention. To this end, food extrusion materials such as that used for the extrusion of “cheese puffs” or puffed cereals may be used. These combine controllable temperature and pressure conditions with an extrusion apparatus. Through careful control of the physical conditions of the machinery, essentially finished, oxidation-reduction product may be extruded and used as-is or in subsequently modified form.

[0120] In accordance with certain embodiments, a film of reactive blend may be doctored onto a surface, such as stainless steel or glass, and the film caused to undergo an oxidation-reduction reaction. The resulting material can resemble a potato chip in overall structure with variable porosity and other physical properties.

[0121] In addition to the use of sponge material, the present invention is also amenable to the use of other organic material capable of imbibing reactive blend. Thus, if a gauze material is used, the resulting oxidation reduction product assumes the form of the gauze. A flannel material will give rise to a relatively thick pad of inorganic material from which the organic residue may be removed through the application of heat. Cotton or wool may be employed as may be a host of other organic materials.

[0122] It is also possible to employ inorganic materials and even metals in accordance with the present invention. Thus, inclusion of conductive mesh, wires, or conductive polymers in materials which form the substrate for the oxidation reduction of the reactive blend can give rise to conductive, mineral-based products. Since the minerals may be formed or modified to include a wide variety of different elements, the same may be caused to be catalytic. The combination of a porous, impermeable, catalytic material with conductivity makes the present invention highly amenable to use in fuel cells, catalytic converters, chemical reaction apparatus and the like.

[0123] In this regard, since the conductive and compositional character of the shaped bodies of the present invention may be varied in accordance with preselected considerations, such shapes may be used in electronic and military applications. Thus, the ceramics of the invention may be piezoelectric, may be transparent to microwave radiation and, hence, useful in radomes and the like. They may be ion responsive and, therefore, useful as electrochemical sensors, and in many other ways. The materials of the invention may be formulated so as to act as pharmaceutical excipients, especially when comminuted, as gas scrubber media, for pharmaceutical drug delivery, in biotechnological fermentation apparatus, in laboratory apparatus, and in a host of other applications.

[0124] As will be apparent from a review of the chemistry portion of the present specification, a very large variety of mineral species may be formed. Each of these may be elaborated into shaped bodies as described here and above. For example, transition metal phosphates including those of scandium, titanium, chromium, manganese, iron, cobalt, nickel, copper, and zinc may be elaborated into pigments, phosphors, catalysts, electromagnetic couplers, microwave couplers, inductive elements, zeolites, glasses, and nuclear waste containment systems and coatings as well as many others.

[0125] Rare earth phosphates can form intercalation complexes, catalysts, glasses, ceramics, radiopharmaceuticals, pigments and phosphors, medical imaging agents, nuclear waste solidification media, electro-optic components, electronic ceramics, surface modification materials and many others. Aluminium and zirconium phosphates, for example, can give rise to surface protection coatings, abrasive articles, polishing agents, cements, filtration products and otherwise.

[0126] Alkali and alkaline earth metal phosphates are particularly amenable to low temperature glasses, ceramics, biomaterials, cements, glass-metal sealing materials, glass-ceramic materials including porcelains, dental glasses, electro-optical glasses, laser glasses, specific refractive index glasses, optical filters and the like.

[0127] In short, the combination of easy fabrication, great variability in attainable shapes, low temperature elaboration, wide chemical composition latitude, and the other beneficial properties of the present invention lend it to a wide variety of applications. Indeed, other applications will become apparent as the full scope of the present invention unfolds over time.

[0128] In accordance with the present invention, the minerals formed hereby and the shaped bodies comprising them are useful in a wide variety of industrial, medical, and other fields. Thus, calcium phosphate minerals produced in accordance with preferred embodiments of the present invention may be used in dental and orthopaedic surgery for the restoration of bone, tooth material and the like. The present minerals may also be used as precursors in chemical and ceramic processing, and in a number of industrial methodologies, such as crystal growth, ceramic processing, glass making, catalysis, bioseparations, pharmaceutical excipients, gem synthesis, and a host of other uses. Uniform microstructures of unique compositions of minerals produced in accordance with the present invention confer upon such minerals wide utility and great “value added.” Indeed, submicron microstructure can be employed by products of the invention with the benefits which accompany such microstructures.

[0129] Improved precursors provided by this invention yield lower formation temperatures, accelerated phase transition kinetics, greater compositional control, homogeneity, and flexibility when used in chemical and ceramic processes. Additionally, these chemically-derived, ceramic precursors have fine crystal size and uniform morphology with subsequent potential for very closely resembling or mimicking natural tissue structures found in the body.

[0130] Controlled precipitation of specific phases from aqueous solutions containing metal cations and phosphate anions represents a difficult technical challenge. For systems containing calcium and phosphate ions, the situation is further complicated by the multiplicity of phases that may be involved in the crystallization reactions as well as by the facile phase transformations that may proceed during mineralization. The solution chemistry in aqueous systems containing calcium and phosphate species has been scrupulously investigated as a function of pH, temperature, concentration, anion character, precipitation rate, digestion time, etc. (P. Koutsoukos, Z. Amjad, M. B. Tomson, and G. H. Nancollas, “Crystallization of calcium phosphates. A constant composition study,” J. Am. Chem. Soc. 102: 1553 (1980); A. T. C. Wong. and J. T. Czemuszka, “Prediction of precipitation and transformation behavior of calcium phosphate in aqueous media,” in Hydroxyapatite and Related Materials, pp 189-196 (1994), CRC Press, Inc.; G. H. Nancollas, “In vitro studies of calcium phosphate crystallization,” in Biomineralization—Chemical and Biochemical Perspectives, pp 157-187 (1989)).

[0131] Solubility product considerations impose severe limitations on the solution chemistry. Furthermore, methods for generating specific calcium phosphate phases have been described in many technical articles and patents (R. Z. LeGeros, “Preparation of octacalcium phosphate (OCP): A direct fast method.” Calcif. Tiss Lnt. 37: 194 (1985)) As discussed above, none of this aforementioned art employs the present invention.

[0132] Several sparingly soluble calcium phosphate crystalline phases, so called “basic” calcium phosphates, have been characterized, including alpha- and beta-tricalcium phosphate (α-TCP, β-TCP, Ca 3 (PO 4 ) 2 ), tetracalcium phosphate (TTCP, Ca 4 (PO 4 ) 2 O), octacalcium phosphate (OCP, Ca 4 H(PO 4 ) 3 .-nH 2 O, where 2<n<3), and calcium hydroxyapatite (HAp, Ca 5 (PO 4 ) 3 (OH)). Soluble calcium phosphate phases, so called “acidic” calcium phosphate crystalline phases, include dicalcium phosphate dihydrate (brushite -DCPD, CaHPO 4 .H 2 O), dicalcium phosphate anhydrous (monetite-DCPA, CaHPO 4 ), monocalcium phosphate monohydrate (MCPM, Ca(H 2 PO 4 ) 2 —H 2 O), and monocalcium phosphate anhydrous (MCPA, Ca(H 2 PO 4 ) 2 ). These calcium phosphate compounds are of critical importance in the area of bone cements and bone grafting materials. The use of DCPD, DCPA, α-TCP, β-TCP, TTCP, OCP, and HAp, alone or in combination, has been well documented as biocompatible coatings, fillers, cements, and bone-forming substances (F. C. M. Driessens, M. G. Boltong, O. Bermudez, J. A. Planell, M. P. Ginebra, and E. Fernandez, “Effective formulations for the preparation of calcium phosphate bone cements,” J. Mat. Sci.: Mat. Med. 5: 164 (1994); R. Z. LeGeros, “Biodegradation and bioresorption of calcium phosphate ceramics,” Clin. Mat. 14(1): 65 (1993); K. Ishikawa, S. Takagi, L. C. Chow, and Y. Ishikawa, “Properties and mechanisms of fast-setting calcium phosphate cements,” J. Mat. Sci.: Mat. Med. 6: 528 (1995); A. A. Mirtchi, J. Lemaitre, and E. Munting, “Calcium phosphate cements: Effect of fluorides on the setting and hardening of beta-tricalcium phosphate—dicalcium phosphate—calcite cements,” Biomat. 12: 505 (1991); J. L. Lacout, “Calcium phosphate as bioceramics,” in Biomaterials—Hard Tissue Repair and Replacement, pp 81-95 (1992), Elsevier Science Publishers).

[0133] Generally, these phases are obtained via thermal or hydrothermal conversion of (a) solution-derived precursor calcium phosphate materials, (b) physical blends of calcium salts, or (c) natural coral. Thermal transformation of synthetic calcium phosphate precursor compounds to TCP or TTCP is achieved via traditional ceramic processing regimens at high temperature, greater than about 800° C. Thus, despite the various synthetic pathways for producing calcium phosphate precursors, the “basic” calcium phosphate materials used in the art (Ca/P≧1.5) have generally all been subjected to a high temperature treatment, often for extensive periods of time. For other preparations of “basic” calcium phosphate materials, see also H. Monma, S. Ueno, and T. Kanazawa, “Properties of hydroxyapatite prepared by the hydrolysis of tricalcium phosphate,” J. Chem. Tech. Biotechnol. 31: 15 (1981); H. Chaair, J. C. Heughebaert, and M. Heughebaert, “Precipitation of stoichiometric apatitic tricalcium phosphate prepared by a continuous process,” J. Mater. Chem. 5(6): 895 (1995); R. Famery, N. Richard, and P. Boch, “Preparation of alpha- and beta-tricalcium phosphate ceramics, with and without magnesium addition,” Ceram. Int. 20: 327 (1994); Y. Fukase, E. D. Eanes, S. Takagi, L. C. Chow, and W. E. Brown, “Setting reactions and compressive strengths of calcium phosphate cements,” J. Dent. Res. 69(12): 1852 (1990).

[0134] The present invention represents a significant departure from prior methods for synthesizing metal phosphate minerals and porous shaped bodies of these materials, particularly calcium phosphate powders and materials, in that the materials are formed from homogeneous solution using a novel Redox Precipitation Reaction (RPR). They can be subsequently converted to TCP, HAp and/or combinations thereof at modest temperatures and short firing schedules. Furthermore, precipitation from homogeneous solution (PFHS) in accordance with this invention, has been found to be a means of producing particulates of uniform size and composition in a form heretofore not observed in the prior art.

[0135] The use of hypophosphite [H 2 PO 2 ] anion as a precursor to phosphate ion generation has been found to be preferred since it circumvents many of the solubility constraints imposed by conventional calcium phosphate precipitation chemistry and, furthermore, it allows for uniform precipitation at high solids levels. For example, reactions can be performed in accordance with the invention giving rise to product slurries having in excess of 30% solids. Nitrate anion is the preferred oxidant, although other oxidizing agents are also useful.

[0136] The novel use of nitrate anion under strongly acidic conditions as the oxidant for the hypophosphite to phosphate reaction is beneficial from several viewpoints. Nitrate is readily available and is an inexpensive oxidant. It passivates stainless steel (type 316 SS) and is non-reactive to glass processing equipment. Its oxidation byproducts (NO x ) are manageable via well-known pollution control technologies, and any residual nitrate will be fugitive, as NO x under the thermal conversion schedule to which the materials are usually subjected, thus leading to exceedingly pure final materials.

[0137] Use of reagent grade metal nitrate salts and hypophosphorous acid, as practiced in this invention, will lead to metal phosphate phases of great purity.

[0138] Methods for producing useful calcium phosphate-based materials are achieved by reduction-oxidation precipitation reactions (RPR) generally conducted at ambient pressure and relatively low temperatures, usually below 250° C. and preferably below 200° C., most preferably below 150° C. The manner of initiating such reactions is determined by the starting raw materials, their treatment, and the redox electrochemical interactions among them.

[0139] The driving force for the RPR is the concurrent reduction and oxidation of anionic species derived from solution precursors. Advantages of the starting solutions can be realized by the high initial concentrations of ionic species, especially calcium and phosphorus species. It has been found that the use of reduced phosphorus compounds leads to solution stability at ionic concentrations considerably greater than if fully oxidized [PO 4 ] −3 species were used. Conventional processing art uses fully oxidized phosphorus oxoanion compounds and is, consequently, hindered by pH, solubility, and reaction temperature constraints imposed by the phosphate anion.

[0140] Typical reducible species are preferably nitric acid, nitrate salts (e.g. Ca(NO 3 ) 2 4H 2 O), or any other reducible nitrate compound, which is highly soluble in water. Other reducible species include nitrous acid (HNO 2 ) or nitrite (NO 2 ) salts.

[0141] Among the oxidizable species which can be used are hypophosphorous acid or hypophosphite salts [e.g. Ca(H 2 PO 2 ) 2 ] which are highly soluble in water. Other oxidizable species which find utility include acids or salts of phosphites (HPO 3 2− ), pyrophosphites (H 2 P 2 O 5 2− ), thiosulfate (S 2 O 3 2− ), tetrathionate (S 4 O 6 2− ), dithionite (S 2 O 4 2− ) trithionate (S 3O 6 2− ), sulfite (SO 3 2− ), and dithionate (S 2 O 6 2− ). In consideration of the complex inorganic chemistry of the oxoanions of Groups 5B, 6B, and 7B elements, it is anticipated that other examples of oxidizable anions can be utilized in the spirit of this invention.

[0142] The cation introduced into the reaction mixture with either or both of the oxidizing or reducing agents are preferably oxidatively stable (i.e. in their highest oxidation state). However, in certain preparations, or to effect certain reactions, the cations may be introduced in a partially reduced oxidation state. Under these circumstances, adjustment in the amount of the oxidant will be necessary in order to compensate for the electrons liberated during the oxidation of the cations during RPR.

[0143] It is well known in the art that for solutions in equilibrium with ionic precipitates, the solute concentrations of the reactant ions are dictated by solubility product relationships and supersaturation limitations. For the Ca 2+ —[PO 4 ] −3 system, these expressions are exceedingly complicated, due in large part to the numerous pathways (i.e., solid phases) for relieving the supersaturation conditions. Temperature, pH, ionic strength, ion pair formation, the presence of extraneous cations and anions all can affect the various solute species equilibria and attainable or sustainable supersaturation levels (F. Abbona, M. Franchini-Angela, and R. Boistelle, “Crystallization of calcium and magnesium phosphates from solutions of medium and low concentrations,” Cryst. Res. Technol. 27: 41 (1992); G. H. Nancollas, “The involvement of calcium phosphates in biological mineralization and demineralization processes,” Pure Appl. Chem. 64(11): 1673 (1992); G. H. Nancollas and J. Zhang, “Formation and dissolution mechanisms of calcium phosphates in aqueous systems,” in Hydroxyapatite and Related Materials, pp 73-81 (1994), CRC Press, Inc.; P. W. Brown, N. Hocker, and S. Hoyle, “Variations in solution chemistry during the low temperature formation of hydroxyapatite,” J. Am. Ceram. Soc. 74(8): 1848 (1991); G. Vereecke and J. Lemaitre, “Calculation of the solubility diagrams in the system Ca(OH) 2 —H 3 PO 4 —KOH—HNO 3 —CO 2 —H 2 O, ” J. Cryst. Growth 104: 820 (1990); A. T. C. Wong and J. T. Czernuszka, “Prediction of precipitation and transformation behavior of calcium phosphate in aqueous media,” in Hydroxyapatite and Related Materials, pp 189-196 (1994), CRC Press, Inc.; G. H. Nancollas, “In vitro studies of calcium phosphate crystallization,” in Biomineralization—Chemical and Biochemical Perspectives, pp 157-187 (1989)).

[0144] Additionally, while thermodynamics will determine whether a particular reaction is possible, kinetic effects may be very much more important in explaining the absence or presence of particular calcium phosphate phases during precipitation reactions.

[0145] In the practice of certain preferred embodiments of this invention to give rise to calcium phosphates, soluble calcium ion is maintained at concentrations of several molar in the presence of soluble hypophosphite anion which is, itself, also at high molar concentrations. The solution is also at a very low pH due to the presence of nitric and hypophosphorous acids. Indeed, such solutions of calcium and hypophosphite ions can be stable indefinitely with respect to precipitation, at room temperature or below. In contrast, it is impossible (in the absence of ion complexation or chelating agents) to simultaneously maintain calcium ions and phosphate anions at similar concentrations as a solid phase would immediately precipitate to relieve the supersaturation. Upon oxidation of the hypophosphite ion to phosphite and, subsequently, to phosphate, calcium phosphate phases are rapidly precipitated from homogeneous solution under solution conditions unique (concentration, pH, ionic strength) for the formation of such materials. The combination of homogeneous generation of precipitating anion, rapid precipitation kinetics, and unique thermodynamic regime results in the formation of calcium phosphate precursors having unique size and morphological characteristics, surface properties, and reactivities.

[0146] The foregoing consideration will also apply to minerals other than the calcium phosphates. Perforce, however, the phase diagrams, equilibrium conditions and constituent mineral phases will differ in each family of minerals.

[0147] Uniformly sized and shaped particles of metal salts comprised of one or more metal cations in combination with one or more oxoacid anions can result from the present general method for the controlled precipitation of said metal salts from aqueous solutions. These proceed via the in situ homogeneous production of simple or complex oxoacid anions of one or more of the nonmetallic elements, Group 5B and 6B (chalcogenides), and 7B (halides). The first oxoacid anion undergoes oxidation (increase in chemical oxidation state) to generate the precipitant anionic species along with concurrent reduction (decrease in chemical oxidation state) of the nonmetallic element of a second, dissimilar oxoacid anion, all oxoacid anions initially being present in solution with one or more metal cations known to form insoluble salts with the precipitant anion. The metal cations are, preferably, oxidatively stable, but may undergo oxidation state changes themselves under certain conditions.

[0148] RPR is induced preferably by heating a homogeneous solution, so as to promote the onset and continuation of an exothermic redox reaction. This exothermic reaction results in the generation of gases, usually various nitrogen oxide gases such as NO x , where 0.5<x<2, as the soluble reduced phosphorus species are converted to precipitating anions which then homogeneously precipitate the calcium ions from the reaction medium. At this stage, the reaction is substantially complete, resulting in an assemblage of ultrafine precipitated particles of the predetermined calcium-phosphate stoichiometry. The reaction yield is high as is the purity of the reaction products.

[0149] The use of alternate heating methods to initiate and complete the RPR reaction may offer utility in the formation of scaffold structures. One such power source is microwave energy, as found in conventional 600-1400W home microwave ovens. The benefit of the use of microwaves is the uniformity of the heating throughout the entire reaction mass and volume as opposed to the external-to-internal, thermal gradient created from traditional conduction/convection/radiant heating means. The rapid, internal, uniform heating condition created by the use of microwave energy provides for rapid redox reaction initiation and drying. The excess RPR liquid is expelled to the outer surface of the cellulose body and flashes off to form an easily removed deposit on the surface. The rapid rate of heating and complete removal of the fugitive substructure alters the particulate structure resulting in greater integral strength. The speed of heating and initiation of the RPR reaction may also minimize crystal grain growth. Intermediate precursor mineral powders are homogeneously precipitated from solution. Moderate heat treatments at temperatures <500° C., can be used to further the transformation to various phosphate containing phases. Proper manipulations of chemistry and process conditions have led to mono- and multiphasic compounds with unique crystal morphologies, see, e.g. FIGS. 1 and 2 .

[0150] The nitrate/hypophosphite redox system involves a hypophosphite oxidation to phosphate (p +1 to p +5 , a 4e oxidation) as depicted in the following equations (E 0 /V from N. N. Greenwood and A. Earnshaw, “Oxoacids of phosphorus and their salts,” in Chemistry of the Elements, pp 586-595 (1984), Pergamon Press): 1

Reduction potential at pH 0, 25° C.
Reaction E O /V
H 3 PO 3 + 2H + + 2e = H 3 PO 2 + H 2 O −0.499 (1)
H 3 PO 4 = 2H + + 2e = H 3 PO 3 + H 2 O −0.276 (2)
H 3 PO 4 + 4H + + 4e = H 3 PO 2 + H 2 O −0.775 Overall (3)

[0151] and a nitrate reduction to NO x (N +5 to N +3 or N +2 , either a 2e or a 3e reduction) as depicted in the following equations: 2

Reduction potential at pH 0, 25° C.
Reaction E O /V
2NO 3 + 4H + + 2e = N 2 O 4 + 2H 2 O 0.803 (4)
NO 3 + 3H + + 2e = HNO 2 + H 2 O 0.94  (5)
NO 3 + 4H + + 3e = NO + 2H 2 O 0.957 (6)

[0152] Chemical reactions are conveniently expressed as the sum of two (or more) electrochemical half-reactions in which electrons are transferred from one chemical species to another. According to electrochemical convention, the overall reaction is represented as an equilibrium in which the forward reaction is stated as a reduction (addition of electrons), i.e.:

Oxidized species+ne =Reduced species

[0153] For the indicated equations at pH=0 and 25° C., the reaction is spontaneous from left to right if E 0 (the reduction potential) is greater than 0, and spontaneous in the reverse direction if E o is less than 0.

[0154] From the above reactions and associated electrochemical potentials, it is apparent that nitrate is a strong oxidant capable of oxidizing hypophosphite (P +1 ) to phosphite (p +3 ) or to phosphate (P +5 ) regardless of the reduction reaction pathway, i.e., whether the reduction process occurs according to Equation 4, 5, or 6. If an overall reaction pathway is assumed to involve a combination of oxidation reaction (Eq.3) (4e exchange) and reduction reaction (Eq.6) (3e exchange), one can calculate that in order for the redox reaction to proceed to completion, 4/3 mole of NO 3 must be reduced to NO per mole of hypophosphite ion to provide sufficient electrons. It is obvious to one skilled in the art that other redox processes can occur involving combinations of the stated oxidation and reduction reactions.

[0155] Different pairings of oxidation and reduction reactions can be used to generate products according to the spirit of this invention. Indeed, the invention generally allows for the in situ homogeneous production of simple or complex oxoacid anions in aqueous solution in which one or more nonmetallic elements such as Group 5B and 6B (chalcogenuides), and 7B (halides) comprising the first oxoacid anion undergoes oxidation to generate the precipitant anionic species along with concurrent reduction of the nonmetallic element of a second, dissimilar oxoacid anion.

[0156] In each of the above scenarios, the key is the reduction-oxidation reaction at high ionic concentrations leading to the homogenous precipitation from solution of novel calcium phosphate powders. Never before in the literature has the ability to form such phases, especially calcium-phosphate phases, been reported under the conditions described in this invention.

[0157] Specific embodiments of the invention utilize the aforementioned processes to yield unique calcium phosphate precursor minerals that can be used to form a self-setting cement or paste. Once placed in the body, these calcium phosphate cements (CPC) will be resorbed and remodeled (converted) to bone. A single powder consisting of biphasic minerals of varying Ca/P ratio can be mixed to yield self-setting pastes that convert to type-B carbonated apatite (bone mineral precursor) in vivo.

[0158] The remodeling behavior of a calcium phosphate bioceramic to bone is dictated by the energetics of the surface of the ceramic and the resultant interactions with osteoclastic cells on approach to the interface. Unique microstructures can yield accelerated reactivity and, ultimately, faster remodeling in vivo. The compositional flexibility in the fine particles of this invention offers adjustable reactivity in vivo. The crystallite size and surface properties of the resultant embodiments of this invention are more similar to the scale expected and familiar to the cells found in the body. Mixtures of powders derived from the processes of this invention have tremendous utility as calcium phosphate cements (CPCs).

[0159] An aqueous solution can be prepared in accordance with the present invention and can be imbibed into a sacrificial organic substrate of desired shape and porosity, such as a cellulose sponge. The solution-soaked substrate is subjected to controlled temperature conditions to initiate the redox precipitation reaction. After the redox precipitation reaction is complete, a subsequent heating step is employed to combust any remaining organic material and/or promote phase changes. The resultant product is a porous, inorganic material which mimics the shape, porosity and other aspects of the morphology of the organic substrate.

[0160] It is anticipated that the porous inorganic materials of the present invention would be suitable for a variety of applications. FIG. 3 depicts a discoidal filter scaffold 16 , which is prepared in accordance with the present invention, and enclosed within an exterior filter housing 18 for filtration or bioseparation applications. Depending upon its end use, discoidal filter scaffold 16 can be a biologically active, impregnated porous scaffold. Arrow 20 represents the inlet flow stream. Arrow 22 represents the process outlet stream after passing through discoidal filter scaffold 16 .

[0161] FIG. 4 illustrates a block of the porous inorganic material that is used as a catalyst support within a two stage, three way hot gas reactor or diffusor. Items 30 and 32 illustrate blocks of the porous material used as catalytically impregnated scaffolds. Items 30 and 32 may be composed of the same or different material. Both 30 and 32 , however, are prepared in accordance with an embodiment of the present invention. Item 34 depicts the first stage catalyst housing, which may be comprised of a ferrous-containing material, and encloses item 30 . Item 36 depicts the second stage catalyst housing, which may be comprised of a ferrous-containing material, and encloses item 32 . Item 38 represents the connector pipe, which is comprised of the same material as the housings 34 and 36 , and connects both 34 and 36 . Arrow 40 represents the raw gas inlet stream prior to passing through both blocks of catalytically impregnated scaffold (items 30 and 32 ). Arrow 42 , lastly, represents the processed exhaust gas stream.

[0162] In other embodiments of the present invention, the inorganic porous material is a calcium phosphate scaffolding material that may be employed for a variety of uses. FIG. 5 illustrates a block of the calcium phosphate scaffolding material 55 that may be inserted into a human femur and used for cell seeding, drug delivery, protein adsorption, growth factor introduction or other biomedical applications. Femoral bone 51 is comprised of metaphysis 52 , Haversian canal 53 , diaphysis 54 and cortical bone 56 . The calcium phosphate scaffolding material 55 is inserted into an excavation of the femoral bone as shown and ties into the Haversian canal allowing cell seeding, drug delivery, or other applications. Scaffolding material 55 can be used in the same manner in a variety of human or mammalian bones.

[0163] FIG. 6A shows the calcium phosphate material of the present invention formed into the shape of a calcium phosphate sleeve 60 . Item 62 depicts the excavated cavity which can be formed via machining or other means. Item 64 presents a plurality of threads which can be coated with bioactive bone cement. FIG. 6B shows the calcium phosphate sleeve 60 inserted into the jaw bone 66 and gum 67 . The calcium phosphate sleeve 60 may be fixed in place via pins, bone cement, or other mechanical means of adhesion. An artificial tooth or dental implant 68 can then be screwed into sleeve 60 by engaging threads 64 .

[0164] FIG. 7A shows the porous, calcium phosphate scaffolding material 70 , prepared in accordance with an embodiment of the present invention, which is machined or molded to patient specific dimensions. FIG. 7B depicts the use of the material 70 that is formed into the shape of craniomaxillofacial implant 76 , a zygomatic reconstruction 72 , or a mandibular implant 74 .

[0165] FIG. 8A depicts a plug of the porous, calcium phosphate scaffolding material 80 . FIG. 8B illustrates plug 80 which is inserted into an excavation site 83 within a human knee, below the femur 81 and above the tibia 82 , for use in a tibial plateau reconstruction. Plug 80 is held in place or stabilized via a bone cement layer 84 .

[0166] FIG. 9 shows the calcium phosphate scaffolding material within a human femur that is used as a block 92 for bulk restoration or repair of bulk defects in metaphyseal bone or oncology defects, or as a sleeve 94 for an orthopaedic screw, rod or pin 98 augmentation. Item 99 depicts an orthopaedic plate anchored by the orthopaedic device item 98 . Bone cement layer 96 surrounds and supports sleeve 94 in place.

[0167] Lastly, FIGS. 10A and 10B depict the use of the calcium phosphate scaffolding material as a receptacle sleeve 100 that is inserted into the body to facilitate a bipolar hip replacement. Alternatively, the receptacle sleeve may be comprised of other materials known in the art. Cavity 102 is machined to accommodate the insertion of a metallic ball joint implant or prosthesis 103 . An orthopaedic surgeon drills a cavity or furrow into the bone 101 to receive sleeve 100 . Sleeve 100 is then affixed to the surrounding bone via a bioactive or biocompatible bone cement layer 104 or other means. On the acetabular side, a femoral head articulation surface 106 is cemented to a bone cement layer 104 that resides within a prepared cavity with material of the present invention, 100 . A high molecular weight polyethylene cup, 105 is used to facilitate articulation with the head of the prosthesis 103 . The metallic ball joint implant or prosthesis 103 is thus inserted into a high molecular weight polyethy